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Recent years have witnessed a revolution in data science and ‘big data’ into which 
psychiatric research has also being drawn. ‘Big data’ has been defined as data sets 
which are so large in size, so fast to change, and so complex in structure, that 
traditional data processing techniques are overwhelmed. [1] The mining and 
exploitation of such big data resources as Electronic Healthcare Records (EHRs) 
presents an exciting challenge to the field of psychiatric epidemiology. The 
number of big data projects within psychiatric research are growing and Stewart 
and Davis’s literature review is therefore timely. [2]  
 
Technological advances in data processing and storage, computer networking, 
mobile technology, and data manipulation, have rendered huge quantities of 
healthcare related data potentially amenable to analysis. Such studies potentially 
offer much larger patient numbers, wider parameters of study, and longer 
timescales of follow-up, than is typical of randomised controlled trials (RCTs) or 
cohort studies. A further advantage of this data is it often arises from naturalistic 
clinical settings, in terms of both clinical practice and patient health and 
comorbidity. Indeed, while often considered the ‘gold standard’ in medical 
research, RCTs do have important limitations, such as overly-strict exclusion 
criteria. Routine clinical datasets can therefore be complementary to RCT data, 
while also making research findings more relevant to everyday clinical practice. In 
addition, the quantity of clinical ‘big data’ potentially allows analysis of rarer 
clinical conditions, or subject areas that would be unlikely to meet ethical approval 
for more conventional studies (for example medication usage in pregnancy). Big 
data studies provide the scale and breadth of patient numbers required for 
stratified, predictive and personalised medicine research. Additionally, 
notwithstanding the many challenges of working with big data, large scale analysis 
of routinely collected healthcare datasets has already demonstrated effectiveness in 
fields such as pharmacovigilance [3] and post-marketing clinical trials.  
 
 As described in detail by Stewart and Davis, the challenging aspects of working 
with ‘big data’ are captured by the taxonomy of ‘Vs’ – volume, velocity and 
variety – first described by Laney [4] and extended since. [1,2] There are 
additional issues to working with healthcare big data specifically, including that 
clinical administrative data is generally not collected, curated or formatted in a 
manner optimised for research, and the inherent sensitivity of the data in terms of 
personal privacy. As the possibilities for healthcare big data expand into such areas 
as text mining and natural language processing of clinical records; near ‘real time’ 
updating of repositories; and incorporation of new data streams from mobile and 
wearable technology, robust systems must be in place to channel the potential data 
deluge. How great a role ‘cloud’ computing and storage will have in this is an 
intriguing question. In healthcare big data, the benefits offered by the cloud in 
increased power and accessibility, and reduced cost, must be weighed against 
concerns over data ownership, encryption and unauthorized access. An additional 
question is whether unique patient identifiers (UPIs) utilised by some national 
healthcare systems can be extended more widely, thereby facilitating securer forms 
of record linkage and de-identification as data is combined. 
 
As with any relatively young scientific field, it is important that health informatics 
does not oversell its early potential. Google Flu Trends is a recent example of a 
machine-learning ‘big data’ approach which has fallen short of initial promise. [1, 
5] Even within more traditional analysis of administrative clinical data, there are 
concerns about data quality and validity: examples including handling of missing 
data; the accuracy of DSM/ICD coding in clinical records [6]; and the use of 
psychiatric medication (which has multiple indications) as a surrogate for 
psychiatric caseness. Further research in these areas is required to guide good 
practice.  
 
An important, and arguably under-researched, aspect of healthcare ‘big data’ is 
ethics and governance. Privacy, informed consent, data stewardship and the long-
term ownership of data by academic and commercial entities, are becoming ever 
more pertinent issues as the pace of data accumulation increases. Data collected 
from individuals with psychiatric illness may come with additional consent and 
privacy concerns. It is important, however, that legitimate concerns about privacy 
do not inadvertently create an excessively restrictive regulatory environment. 
There is a critical role for policymakers in striking the right balance between 
privacy and realising the research potential of big data, as was recently illustrated 
in the debate regarding the European Data Protection Regulation. [7] 
 
Furthermore, the expertise required for high quality big data analysis, ranging from 
data security to statistical modelling and machine learning, increases the scope for 
partnerships between commercial organisations specializing in these skills and 
clinical and academic healthcare entities. A recent example is the collaboration of 
Google Deepmind with Moorfields Eye Hospital, where anonymised access to 
patient records was granted. [8] While such commercial-clinical-academic 
partnerships are a welcome development for the field, it is vital that they take place 
under a strong ethical and research governance framework to ensure clinician and 
patient confidence. [7]   
 
As Stewart and Davis state, the future of big data research in psychiatry requires 
greater involvement of the research community in shaping the structure and 
content of clinical data platforms, rather than just being their passive recipients. 
This will require greater commonality of purpose and priorities between 
researchers, clinicians and patients. In order for EHRs and other administrative 
data to be better optimised for the requirements of large scale psychiatric research, 
GPs, clinical psychiatrists, hospital managers and patients will need to feel 
sufficiently motivated that it is in their interest to make the change.  One way to 
achieve this is to ensure that research priorities align more closely with clinical 
priorities, such as outcomes-focused research.  
 
As health informatics and data science develop as disciplines, they should seek to 
replicate advances that have proved advantageous in other fields. These include 
international collaboration, which has proven transformative in psychiatric 
genetics. The adoption of shared standards in data management, data governance 
and data security would facilitate joint, comparative and replicative big data 
studies between centres (for a summary of current initiatives see [9]). Similarly, 
the successful collaborations with patients and patient advocacy groups that have 
been a feature of clinical trials research provides a template for ‘big data’ as it 
seeks to persuade (sometimes sceptical) policymakers and the wider public of its 
potential.  
 
There is also an urgent need to improve the awareness and training of academic 
psychiatrists regarding data science methods and this should be further developed. 
Raising the profile of ‘big data’ in healthcare research among primary and 
secondary care clinicians, and among other decision-makers within healthcare 
should be an essential aspect of the communication efforts of those engaged in the 
big data field in psychiatry.  
 
As we look to the future, it is gratifying to note a number of important healthcare 
‘big data’ initiatives taking shape. UK Biobank is an early exemplar of combining 
phenotypic, genetic, imaging and wearable technology data, with linkage to 
diverse primary and secondary care records, within an integrated platform that is 
available to researchers worldwide at a relatively low cost. The US Precision 
Medicine Initiative (PMI), announced last year by President Obama, is an attempt 
to do this on an even larger scale. Within psychiatry, the move towards near real-
time access to clinical data incorporated in the SLaM BRC Clinical Record 
Interactive Search (CRIS) [10] will hopefully be among the first of many such 
resources. In addition, we are witnessing a broadening of the horizons of clinical 
record linkage, to encompass linkage to birth cohorts, genetic and imaging 
repositories, but also to other administrative data in social, economic and 
educational fields. [2] This will allow future studies to better model the ‘bio-
psycho-social’ outcomes of psychiatric illness for the benefit of patients, 
researchers and policymakers.  We anticipate further, even more imaginative, uses 
of ‘big data’ resources, such as analysis of social media activity in psychiatric 
research, while recognising the potential biases as well as opportunities therein.  
 
The volume, velocity and variety of big data is already far beyond that which can 
be comprehended and analysed solely by the human mind.  Future developments 
as outlined above will render this even more so. In response to this, further 
innovation of data science techniques - machine learning, parallel computing, 
distributed data analysis, cloud based analysis and storage - is fundamental to the 
future of psychiatric health informatics.  Familiarity with this toolbox of data 
science techniques will become a critical attribute for the psychiatric researcher of 
the 21
st
 century. It should also be central to the strategies of psychiatric research 
funders.  
 
While outlining the opportunities and challenges of ‘big data’ research in 
psychiatry, Stewart and Davis’ review is also a call to the research community to 
play a greater role in shaping the development of these resources. We welcome and 
endorse this perspective.  
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